Skip To Main Content
Gregory Daniel on Muck Rack

Gregory Daniel

Washington, D.C.
As seen in: Eli Lilly and Company, Therapeutic Innovation & Regulatory Science, Color Research & Application, Nature, JAMA (The Journal of the American Medical Association), Health Affairs
Eli Lilly. former Deputy Director @DukeMargolis, former Brookings fellow. Editor-In-Chief, TIRS. Health policy. Opinions my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gregory

Contact Gregory, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets - Nature Cell Biology

|
By Kristie Lindsey, Won Jae, Mary Kay, Gregory W. Daniel, Gregory Daniel
| Nature Verified
Abstract Extracellular vesicles and exomere nanoparticles are under intense investigation as sources of clinically relevant cargo. Here we report the discovery of a distinct extracellular nanoparticle, termed supermere. Supermeres are morphologically distinct from exomeres and display a markedly greater uptake in vivo compared with small extracellular vesicles and exomeres. The protein and RNA composition of supermeres differs from small extracellular vesicles and exomeres.
Open in Who Shared Issue with article?

Investigation of a novel variable dosing protocol for radioiodine treatment of feline hyperthyroidism

|
By Wendy A. Morré, David L. Panciera, Gregory Daniel, William Monroe
| pericles.pericles-prod.literatumonline.com
In an attempt to improve outcome of radioiodine treatment, the treatment protocol in our hospital was changed from a fixed dose of 4.5 millicuries (mCi) 131 I to a novel variable dosing treatment with cats tiered to receive 3, 3.5, or 4.5 mCi based on evaluation of scintigraphic findings. This change presented a unique opportunity to compare the 2 methods of radioiodine dose determination.
Open in Who Shared Issue with article?

Investigation of a novel variable dosing protocol for radioiodine treatment of feline hyperthyroidism

|
By Gregory Daniel, William Monroe, Wendy A. Morré, David L. Panciera
| Color Research & Application Verified
Radioiodine is the treatment of choice for hyperthyroidism in cats. The ideal method of dose determination of radioiodine remains controversial. To compare a method of radioiodine dose determination that utilized thyroid scintigraphy with a standard fixed dose for treatment of hyperthyroidism. Fifty‐seven and 23 client‐owned hyperthyroid cats in the variable and fixed dose groups, respectively.
Open in Who Shared Issue with article?
See all 6 articles